Immediate Impact
62 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Evaluation metrics and statistical tests for machine learning
2024 Standout
Works of Alfred Witjes being referenced
A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 with or without intravesical Bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC): CheckMate 9UT.
2019
Lymphotropic Nanoparticle-enhanced MRI in Prostate Cancer: Value and Therapeutic Potential
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alfred Witjes | 130 | 36 | 88 | 48 | 22 | 227 | |
| Shigeyoshi Kamata | 72 | 41 | 93 | 55 | 29 | 218 | |
| Andrea Russo | 163 | 40 | 80 | 48 | 21 | 239 | |
| Wendy Ansell | 149 | 36 | 161 | 49 | 23 | 293 | |
| Friederike Haidl | 82 | 25 | 67 | 32 | 25 | 171 | |
| Abdul Razik | 87 | 24 | 129 | 31 | 33 | 235 | |
| N Daly | 103 | 34 | 52 | 30 | 17 | 223 | |
| Timothy Christmas | 143 | 28 | 166 | 37 | 18 | 274 | |
| Vladislav Gorbatiy | 117 | 21 | 173 | 26 | 20 | 275 | |
| Hong Truong | 51 | 21 | 60 | 28 | 27 | 152 | |
| Ichiro Shintaku | 76 | 40 | 104 | 22 | 18 | 210 |
All Works
Loading papers...